Loading company…
Riskpilot
← Back to search
Sign in
Get full access
G. Trygg, Urolog AB
AB
Active
Org 5569314429
Sandbäcksvägen 27
Medical specialists activities · NACE 8622
Est. 2013
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
SEK 3K
-85% vs 2024
EBITDA margin
-877.1%
+70% vs 2024
Equity ratio
64.6%
Financial strength
Net profit 2025
SEK 155K
+147% vs 2024
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Key figures
Annual report 2025
Revenue
SEK 3K
-85%
EBITDA
SEK -26K
+70%
Net profit
SEK 155K
+147%
Total assets
SEK 1,3M
-18%
Equity
SEK 853K
-5%
Employees
0
—
Company information
Legal name
G. Trygg, Urolog AB
Org number
5569314429
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
13 maj 2013
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Aktiebolaget ska bedriva läkarvård och därmed förenlig verksamhet.
Contact
Address
Sandbäcksvägen 27
Email
gunnar@trygg.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Medical specialists activities
Companies in Södertälje
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
400
36
33
20
3
Staff expenses
—
−0
—
−4
−4
EBITDA
75
15
65
−86
−26
Depreciation & amort.
−31
—
—
—
—
EBIT
44
15
65
−86
−22
Net financials
23
25
0
−327
−328
Profit before tax
176
174
192
−318
202
Tax
−40
−40
−45
−9
−47
Net profit
136
134
146
−327
155
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
2 588
2 450
2 242
1 617
1 320
Equity
1 516
1 466
1 426
903
853
Long-term debt
0
—
—
—
—
Short-term debt
79
124
84
77
54
Total debt
79
124
84
77
54
Financial ratios
5-year trend
EBITDA margin
-877.1%
This company
15.8%
Market median
-5651% vs market
2021
2025
Equity ratio
64.6%
This company
38.2%
Market median
+69% vs market
2021
2025
Return on equity
18.1%
This company
18.4%
Market median
+2% vs market
2021
2025
Net profit margin
5160.7%
This company
8.1%
Market median
+63612% vs market
2021
2025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2021
2025
Debt / equity
0.55×
This company
0.62×
Market median
+11% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
LG
Lars Gunnar Vilhelm Trygg
Board of Directors
2022
EC
Erika Carola C Trygg Mannsikka
Deputy Board Member
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of G. Trygg, Urolog AB also hold positions in
0
other companies.
Person
Role here
Other companies
Lars Gunnar Vilhelm Trygg
Board of Directors
0 companies
Erika Carola C Trygg Mannsikka
Deputy Board Member
0 companies